Drug information for CAMPRAL
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET, DELAYED RELEASE; ORAL
333MG
Prescription
(Reference Drug)
ACAMPROSATE CALCIUM
acamprosate
FOREST LABS
21431
2012-02-01 Letter
2012-01-30 Label
2010-12-15 Letter
2010-12-13 Label
2004-10-18 Review
2004-07-30 Letter
2004-07-30 Label
Drug Adverse Effects information for CAMPRAL
Role code
Indications
Reaction
# Reports
SS
ALCOHOLISM
DRUG INEFFECTIVE
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
INTENTIONAL DRUG MISUSE
10
SS
PRODUCT USED FOR UNKNOWN INDICATION
NERVOUSNESS
10
SS
SMOKING CESSATION THERAPY
DRUG INEFFECTIVE
1
C
ANXIETY
AGGRESSION
1
C
ANXIETY
DEPRESSION
1
C
ANXIETY
INJURY
1
C
ANXIETY
SUICIDE ATTEMPT
1
C
ASTHMA
PAIN
1
C
ASTHMA
SPLENIC INFARCTION
1
C
ASTHMA
THROMBOSIS
1
C
BIPOLAR DISORDER
AGGRESSION
1
C
BIPOLAR DISORDER
DEPRESSION
1
C
BIPOLAR DISORDER
INJURY
1
C
BIPOLAR DISORDER
SUICIDE ATTEMPT
1
C
CONVULSION
AGGRESSION
1
C
CONVULSION
DEPRESSION
1
C
CONVULSION
INJURY
1
C
CONVULSION
SUICIDE ATTEMPT
1
C
INJURY
AGGRESSION
1
C
INJURY
DEPRESSION
1
C
INJURY
INJURY
1
C
INJURY
SUICIDE ATTEMPT
1
C
PAIN
AGGRESSION
1
C
PAIN
DEPRESSION
1
C
PAIN
HYPERTENSIVE HEART DISEASE
2
C
PAIN
INJURY
1
C
PAIN
SUICIDE ATTEMPT
1
C
PAIN
TOXICITY TO VARIOUS AGENTS
2
C
SMOKING CESSATION THERAPY
AGGRESSION
1
C
SMOKING CESSATION THERAPY
DEPRESSION
1
C
SMOKING CESSATION THERAPY
INJURY
1
C
SMOKING CESSATION THERAPY
SUICIDE ATTEMPT
1
Ads by Google